NCT03447743View on ClinicalTrials.gov

Re-entry XR-NTX for Rural Individuals With Opioid Use Disorder

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

September 11, 2019

Primary Completion Date

March 9, 2022

Study Completion Date

March 9, 2022

Conditions
Opioid Dependence
Interventions
DRUG

XR-NTX community location

XR-NTX will be administered at the local health care clinic

Trial Locations (1)

40536

University of Kentucky, Lexington

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Michele Staton

OTHER

NCT03447743 - Re-entry XR-NTX for Rural Individuals With Opioid Use Disorder | Biotech Hunter | Biotech Hunter